Treatment Approaches for Therapy-Related AML, MDS Based on Mutation Profiles
This video examines different mutational profiles of therapy-related myeloid neoplasms and how they can affect approaches to treatment.
In this video, Michael Heuser, MD, of the Hannover Medical School in Germany, discusses different mutational profiles of therapy-related myeloid neoplasms, such as acute myeloid leukemia (AML) and myelodysplastic syndromes, and how these genetic profiles can affect approaches to treatment.
Dr. Heuser spoke at an education session on AML at the 58th Annual Meeting of the American Society of Hematology, held December 3–6 in San Diego, California.
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
July 30th 2025Researchers have found that donor age is a key determinant of outcomes in hematopoietic cell transplantation, with younger donors associated with significantly better survival and lower rates of GVHD.
